Scancell Holdings plc (LON:SCLP – Get Free Report) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 11.20 ($0.14) and traded as low as GBX 9.30 ($0.12). Scancell shares last traded at GBX 9.55 ($0.12), with a volume of 198,395 shares.
Scancell Price Performance
The firm has a 50-day moving average price of GBX 10.26 and a 200 day moving average price of GBX 11.20. The stock has a market capitalization of £90.93 million, a P/E ratio of -955.00 and a beta of 0.34. The company has a debt-to-equity ratio of 61.41, a quick ratio of 13.01 and a current ratio of 8.63.
About Scancell
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.
Read More
- Five stocks we like better than Scancell
- How to Use Stock Screeners to Find Stocks
- The 3 Hottest Insiders Buys This Month
- What is the NASDAQ Stock Exchange?
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- Short Selling: How to Short a Stock
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.